 Angela Rachubinski
Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 25 | 2026 | 525 | 4.210 |
Why?
| | Janus Kinase Inhibitors | 3 | 2024 | 28 | 1.840 |
Why?
| | Piperidines | 3 | 2024 | 222 | 1.660 |
Why?
| | Pyrimidines | 3 | 2024 | 530 | 1.430 |
Why?
| | Neural Stem Cells | 2 | 2012 | 168 | 0.630 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2024 | 43 | 0.350 |
Why?
| | tau Proteins | 1 | 2012 | 105 | 0.340 |
Why?
| | Autism Spectrum Disorder | 1 | 2016 | 423 | 0.330 |
Why?
| | Stem Cell Transplantation | 1 | 2012 | 189 | 0.330 |
Why?
| | Autoimmunity | 3 | 2024 | 933 | 0.270 |
Why?
| | Heart Defects, Congenital | 3 | 2026 | 910 | 0.270 |
Why?
| | Cognition Disorders | 1 | 2012 | 544 | 0.270 |
Why?
| | Human Development | 1 | 2025 | 21 | 0.230 |
Why?
| | Proteome | 4 | 2026 | 513 | 0.210 |
Why?
| | Immunoglobulins | 1 | 2025 | 163 | 0.210 |
Why?
| | Erythropoiesis | 1 | 2024 | 57 | 0.210 |
Why?
| | Heme | 1 | 2024 | 90 | 0.200 |
Why?
| | Blood-Brain Barrier | 1 | 2025 | 160 | 0.200 |
Why?
| | Pyrroles | 1 | 2024 | 220 | 0.200 |
Why?
| | Cognition | 1 | 2012 | 1271 | 0.200 |
Why?
| | Cytokines | 4 | 2024 | 2069 | 0.190 |
Why?
| | Receptors, Interferon | 2 | 2023 | 60 | 0.190 |
Why?
| | Young Adult | 6 | 2025 | 14254 | 0.190 |
Why?
| | Biomedical Research | 2 | 2026 | 719 | 0.180 |
Why?
| | Interferon-alpha | 2 | 2019 | 193 | 0.170 |
Why?
| | Trisomy | 2 | 2019 | 78 | 0.170 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 15 | 0.170 |
Why?
| | Adolescent | 7 | 2025 | 22577 | 0.170 |
Why?
| | Aging | 1 | 2012 | 1973 | 0.170 |
Why?
| | Adult | 11 | 2025 | 40881 | 0.160 |
Why?
| | Child, Preschool | 6 | 2025 | 11868 | 0.160 |
Why?
| | Sex Characteristics | 1 | 2025 | 789 | 0.150 |
Why?
| | Female | 16 | 2026 | 79045 | 0.150 |
Why?
| | Humans | 23 | 2026 | 145783 | 0.150 |
Why?
| | Brain | 1 | 2012 | 2969 | 0.150 |
Why?
| | Animals, Newborn | 2 | 2012 | 896 | 0.150 |
Why?
| | Kynurenine | 1 | 2019 | 114 | 0.140 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2023 | 534 | 0.140 |
Why?
| | Behavior, Animal | 2 | 2012 | 520 | 0.140 |
Why?
| | Transcriptome | 4 | 2026 | 1042 | 0.140 |
Why?
| | Male | 12 | 2026 | 73011 | 0.140 |
Why?
| | Disease Models, Animal | 4 | 2026 | 4568 | 0.140 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 420 | 0.130 |
Why?
| | Child | 7 | 2025 | 22740 | 0.130 |
Why?
| | Autoantibodies | 1 | 2024 | 1509 | 0.130 |
Why?
| | Liver | 1 | 2026 | 1899 | 0.130 |
Why?
| | Hypoxia | 1 | 2024 | 1199 | 0.120 |
Why?
| | Signal Transduction | 3 | 2024 | 5224 | 0.120 |
Why?
| | Mice | 7 | 2026 | 18356 | 0.120 |
Why?
| | Animals | 10 | 2026 | 38102 | 0.120 |
Why?
| | Case-Control Studies | 4 | 2025 | 3634 | 0.110 |
Why?
| | Infant | 3 | 2025 | 10091 | 0.110 |
Why?
| | Cell Differentiation | 3 | 2023 | 2050 | 0.100 |
Why?
| | Drinking Behavior | 1 | 2012 | 15 | 0.090 |
Why?
| | Metabolome | 2 | 2026 | 391 | 0.090 |
Why?
| | Dentate Gyrus | 1 | 2012 | 41 | 0.090 |
Why?
| | Cell Size | 1 | 2012 | 93 | 0.090 |
Why?
| | Avoidance Learning | 1 | 2012 | 63 | 0.090 |
Why?
| | Neuroimmunomodulation | 1 | 2012 | 67 | 0.090 |
Why?
| | Maze Learning | 1 | 2012 | 105 | 0.090 |
Why?
| | Interferons | 2 | 2023 | 186 | 0.090 |
Why?
| | 1-Methyl-4-phenylpyridinium | 1 | 2011 | 5 | 0.090 |
Why?
| | Genetic Variation | 1 | 2016 | 977 | 0.090 |
Why?
| | Cell Count | 1 | 2012 | 319 | 0.090 |
Why?
| | NADPH Oxidases | 1 | 2011 | 122 | 0.080 |
Why?
| | Dopaminergic Neurons | 1 | 2011 | 68 | 0.080 |
Why?
| | Green Fluorescent Proteins | 1 | 2012 | 407 | 0.080 |
Why?
| | Middle Aged | 4 | 2025 | 36309 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2012 | 1300 | 0.070 |
Why?
| | Cell Survival | 1 | 2012 | 1104 | 0.070 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 611 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1723 | 0.070 |
Why?
| | Proteomics | 2 | 2025 | 1188 | 0.060 |
Why?
| | Neoplasms | 1 | 2023 | 2913 | 0.060 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2191 | 0.060 |
Why?
| | Hippocampus | 1 | 2012 | 973 | 0.060 |
Why?
| | Phenotype | 2 | 2026 | 3170 | 0.060 |
Why?
| | Inflammation | 1 | 2017 | 2884 | 0.060 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1777 | 0.050 |
Why?
| | Cells, Cultured | 1 | 2012 | 4151 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2026 | 163 | 0.050 |
Why?
| | Erythropoietin | 1 | 2024 | 100 | 0.050 |
Why?
| | Biomarkers | 2 | 2025 | 4302 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 89 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 73 | 0.040 |
Why?
| | Gene Silencing | 1 | 2023 | 202 | 0.040 |
Why?
| | Neuroimaging | 1 | 2024 | 300 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2024 | 443 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2023 | 372 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 47 | 0.040 |
Why?
| | Cell Line | 2 | 2019 | 2823 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 317 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2021 | 193 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 24 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2026 | 630 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 56 | 0.040 |
Why?
| | Immunotherapy | 1 | 2024 | 668 | 0.040 |
Why?
| | Genome-Wide Association Study | 1 | 2025 | 1430 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 53 | 0.030 |
Why?
| | Cell Lineage | 1 | 2019 | 378 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2025 | 2181 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2019 | 226 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 411 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2025 | 2399 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2019 | 784 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1165 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1133 | 0.030 |
Why?
| | Cohort Studies | 1 | 2026 | 6033 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 5993 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1478 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1736 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2017 | 314 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 733 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 923 | 0.020 |
Why?
| | Obesity | 1 | 2026 | 3118 | 0.020 |
Why?
| | Prospective Studies | 1 | 2025 | 8078 | 0.020 |
Why?
| | Quality of Life | 1 | 2025 | 3211 | 0.020 |
Why?
| | Losartan | 1 | 2011 | 13 | 0.020 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2011 | 38 | 0.020 |
Why?
| | Herbicides | 1 | 2011 | 27 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1812 | 0.020 |
Why?
| | Electron Transport Complex I | 1 | 2011 | 42 | 0.020 |
Why?
| | Oxidants | 1 | 2011 | 99 | 0.020 |
Why?
| | Substantia Nigra | 1 | 2011 | 64 | 0.020 |
Why?
| | Protein Subunits | 1 | 2011 | 229 | 0.020 |
Why?
| | Risk Factors | 1 | 2025 | 10919 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2011 | 335 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 638 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 17330 | 0.010 |
Why?
| | Rats | 1 | 2011 | 5585 | 0.010 |
Why?
|
|
Rachubinski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|